Guanhao Biotech Co.,Ltd. (300238.SZ)
CNY 13.98
(-1.48%)
CNY 13.98
(-1.48%)
| Year | Revenue | Revenue Growth |
|---|---|---|
| 2023 | 399.81 Million CNY | 5.97% |
| 2022 | 377.28 Million CNY | -22.84% |
| 2021 | 488.98 Million CNY | 11.91% |
| 2020 | 436.95 Million CNY | -0.21% |
| 2019 | 437.88 Million CNY | -4.49% |
| 2018 | 458.46 Million CNY | 1.8% |
| 2017 | 450.36 Million CNY | 43.98% |
| 2016 | 312.78 Million CNY | 38.3% |
| 2015 | 226.17 Million CNY | 18.82% |
| 2014 | 190.35 Million CNY | 12.97% |
| 2013 | 168.5 Million CNY | 14.61% |
| 2012 | 147.02 Million CNY | 14.4% |
| 2011 | 128.51 Million CNY | 25.23% |
| 2010 | 102.61 Million CNY | 56.5% |
| 2009 | 65.56 Million CNY | 86.32% |
| 2008 | 35.19 Million CNY | 57.28% |
| 2007 | 22.37 Million CNY | 0.0% |
| Year | Revenue | Revenue Growth |
|---|---|---|
| 2024 Q1 | 90.58 Million CNY | -3.62% |
| 2024 Q2 | 97.16 Million CNY | 7.26% |
| 2024 Q3 | 88.43 Million CNY | -8.98% |
| 2023 Q2 | 98.12 Million CNY | -12.92% |
| 2023 FY | 399.81 Million CNY | 5.97% |
| 2023 Q4 | 93.98 Million CNY | -4.22% |
| 2023 Q1 | 112.68 Million CNY | 35.27% |
| 2023 Q3 | 98.13 Million CNY | 0.0% |
| 2022 Q1 | 122.92 Million CNY | 5.07% |
| 2022 Q4 | 83.3 Million CNY | -8.57% |
| 2022 Q2 | 79.94 Million CNY | -34.96% |
| 2022 Q3 | 91.1 Million CNY | 13.96% |
| 2022 FY | 377.28 Million CNY | -22.84% |
| 2021 Q4 | 116.99 Million CNY | 6.75% |
| 2021 Q3 | 109.59 Million CNY | -18.19% |
| 2021 Q2 | 133.95 Million CNY | 4.3% |
| 2021 Q1 | 128.44 Million CNY | 8.94% |
| 2021 FY | 488.98 Million CNY | 11.91% |
| 2020 Q3 | 115.43 Million CNY | 4.69% |
| 2020 FY | 436.95 Million CNY | -0.21% |
| 2020 Q4 | 117.9 Million CNY | 2.14% |
| 2020 Q2 | 110.26 Million CNY | 18.12% |
| 2020 Q1 | 93.34 Million CNY | -21.99% |
| 2019 Q3 | 110.54 Million CNY | 10.11% |
| 2019 FY | 437.88 Million CNY | -4.49% |
| 2019 Q1 | 107.28 Million CNY | -29.39% |
| 2019 Q4 | 119.66 Million CNY | 8.25% |
| 2019 Q2 | 100.39 Million CNY | -6.42% |
| 2018 Q3 | 111.32 Million CNY | -4.04% |
| 2018 Q4 | 151.93 Million CNY | 36.48% |
| 2018 FY | 458.46 Million CNY | 1.8% |
| 2018 Q2 | 116 Million CNY | 46.5% |
| 2018 Q1 | 79.18 Million CNY | -41.83% |
| 2017 FY | 450.36 Million CNY | 43.98% |
| 2017 Q1 | 86.94 Million CNY | -34.64% |
| 2017 Q2 | 110.98 Million CNY | 27.65% |
| 2017 Q3 | 116.31 Million CNY | 4.8% |
| 2017 Q4 | 136.12 Million CNY | 17.03% |
| 2016 Q4 | 133.02 Million CNY | 82.32% |
| 2016 FY | 312.78 Million CNY | 38.3% |
| 2016 Q2 | 57.65 Million CNY | 17.31% |
| 2016 Q1 | 49.14 Million CNY | -42.5% |
| 2016 Q3 | 72.96 Million CNY | 26.55% |
| 2015 Q4 | 85.47 Million CNY | 58.07% |
| 2015 FY | 226.17 Million CNY | 18.82% |
| 2015 Q3 | 54.07 Million CNY | 14.72% |
| 2015 Q2 | 47.13 Million CNY | 19.33% |
| 2015 Q1 | 39.49 Million CNY | -39.57% |
| 2014 Q3 | 45.41 Million CNY | 9.25% |
| 2014 Q4 | 65.36 Million CNY | 43.91% |
| 2014 FY | 190.35 Million CNY | 12.97% |
| 2014 Q1 | 38 Million CNY | -25.41% |
| 2014 Q2 | 41.57 Million CNY | 9.37% |
| 2013 Q3 | 41.2 Million CNY | 8.68% |
| 2013 Q2 | 37.91 Million CNY | -1.35% |
| 2013 Q1 | 38.43 Million CNY | 0.79% |
| 2013 FY | 168.5 Million CNY | 14.61% |
| 2013 Q4 | 50.95 Million CNY | 23.68% |
| 2012 Q1 | 42.47 Million CNY | -6.6% |
| 2012 Q2 | 35.26 Million CNY | -16.96% |
| 2012 Q3 | 31.14 Million CNY | -11.68% |
| 2012 Q4 | 38.12 Million CNY | 22.41% |
| 2012 FY | 147.02 Million CNY | 14.4% |
| 2011 FY | 128.51 Million CNY | 25.23% |
| 2011 Q2 | 31.68 Million CNY | 55.12% |
| 2011 Q3 | 30.92 Million CNY | -2.41% |
| 2011 Q4 | 45.47 Million CNY | 47.05% |
| 2011 Q1 | 20.42 Million CNY | -45.62% |
| 2010 FY | 102.61 Million CNY | 56.5% |
| 2010 Q2 | 23.15 Million CNY | 39.35% |
| 2010 Q3 | 25.28 Million CNY | 9.22% |
| 2010 Q4 | 37.56 Million CNY | 48.55% |
| 2010 Q1 | 16.61 Million CNY | 0.0% |
| 2009 FY | 65.56 Million CNY | 86.32% |
| 2008 FY | 35.19 Million CNY | 57.28% |
| 2007 FY | 22.37 Million CNY | 0.0% |